Literature DB >> 6847261

The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome.

M E Ellis, S Ralston.   

Abstract

A review of 80 patients with the polymyalgia rheumatica/giant cell arteritis (PMR/GCA) syndrome has revealed that the erythrocyte sedimentation rate (ESR) is normal in 22.5% of cases at presentation. Too much reliance on the ESR as a screening test led to delay in diagnosis in 10 patients. Serious complications occurred in 4 patients with a normal or minimally raised ESR. Analysis of follow-up data at 4 weeks showed no significant correlation between change in the ESR and change in symptoms, and at subsequent clinical attendances symptoms did not consistently parallel the ESR. Our results cast serious doubts on the use of the ESR as an entirely reliable diagnostic and therapeutic aid in the PMR/GCA syndrome.

Entities:  

Mesh:

Year:  1983        PMID: 6847261      PMCID: PMC1001093          DOI: 10.1136/ard.42.2.168

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

1.  I. Persistently high erythrocyte sedimentation rate; diagnostic and prognostic aspects.

Authors:  A LILJESTRAND; B OLHAGEN
Journal:  Acta Med Scand       Date:  1955

2.  Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica.

Authors:  B Wadman; I Werner
Journal:  Lancet       Date:  1967-03-18       Impact factor: 79.321

3.  Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings.

Authors:  P Fauchald; O Rygvold; B Oystese
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

4.  Polymyalgia rheumatica and giant cell arteritis.

Authors:  L A Healey; F Parker; K R Wilske
Journal:  Arthritis Rheum       Date:  1971 Jan-Feb

5.  Polymyalgia rheumatica and its relation to arteritis temporalis.

Authors:  O A Kogstad
Journal:  Acta Med Scand       Date:  1965-11

6.  Normal erythrocyte sedimentation rate and age.

Authors:  L E Böttiger; C A Svedberg
Journal:  Br Med J       Date:  1967-04-08

7.  Articular and vascular manifestations of polymyalgia rheumatica.

Authors:  M I Bruk
Journal:  Ann Rheum Dis       Date:  1967-03       Impact factor: 19.103

8.  Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study.

Authors:  K A Huston; G G Hunder; J T Lie; R H Kennedy; L R Elveback
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

Review 9.  Giant cell (cranial) arteritis: a clinical review.

Authors:  K A Huston; G G Hunder
Journal:  Am Heart J       Date:  1980-07       Impact factor: 4.749

10.  Prognosis in giant-cell arteritis.

Authors:  E Graham; A Holland; A Avery; R W Russell
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-24
View more
  32 in total

1.  Rapidly developing intimal fibrosis mimicking giant cell arteritis.

Authors:  A Petzold; G T Plant; F Scaravilli
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

2.  Temporal artery biopsy in the management of giant cell arteritis with neuro-ophthalmic complications.

Authors:  P Riordan-Eva; K Landau; J O'Day
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

3.  Giant cell arteritis.

Authors:  L G Clearkin
Journal:  BMJ       Date:  1992-08-29

4.  Giant cell arteritis with normal ESR and/or CRP is rare, but not unique!

Authors:  A Grzybowski; A Justynska
Journal:  Eye (Lond)       Date:  2013-09-20       Impact factor: 3.775

5.  Response to Grzybowski and Justynska.

Authors:  S L Levy; A D Bull; A R Nestel
Journal:  Eye (Lond)       Date:  2013-09-20       Impact factor: 3.775

6.  Interleukin-6 in clinical relapses of polymyalgia rheumatica and giant cell arteritis.

Authors:  D Caplanne; J M Le Parc; J A Alexandre
Journal:  Ann Rheum Dis       Date:  1996-06       Impact factor: 19.103

7.  Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.

Authors:  V Kyle; T E Cawston; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

Review 8.  Giant cell arteritis: difficult decisions in diagnosis, investigation and treatment.

Authors:  E W Paice
Journal:  Postgrad Med J       Date:  1989-10       Impact factor: 2.401

9.  Giant cell arteritis precipitated by a diagnostic trial of prednisolone in suspected polymyalgia rheumatica.

Authors:  P A Reilly; P J Maddison
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

10.  The process from symptom onset to rheumatology clinic in polymyalgia rheumatica.

Authors:  Ediz Dalkılıç; Ayşe Nur Tufan; Emre Hafızoğlu; Merve Hafızoğlu; Fatih Tufan; Ferhat Oksuz; Yavuz Pehlivan; Mustafa Yurtkuran
Journal:  Rheumatol Int       Date:  2014-05-11       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.